Re: Cramer Insmed
Zake. That’s probably good advice today. Regarding focus on the Facts in play. Insmed is no longer a startup. They are a mature company in the Bio field that has not turned a profit, yet. They have a few items in play that they have invested nearly a billion dollars in over the last 10 years. Has it been well spent? Probably not, but they at least have great potential in a few drugs and therapy for conditions that need a lifesaver. I see a lot of positives, but Lewis has no choice but to prove he is capable of getting this across the finish line and make this profitable for all investors.